# Evaluating the Process of Patient Engagement: Insights from a Mixed‐Methods Evaluation of a Cancer Center Patient Advisory Group

**Authors:** Lauren Kearney, Tracy Battaglia, Karina Verma, Sara Shusterman, Michelle Hall, Gemmae Fix, Katrina Steiling

PMC · DOI: 10.1111/hex.70581 · Health Expectations : An International Journal of Public Participation in Health Care and Health Policy · 2026-01-24

## TL;DR

This study evaluates how a cancer center's patient advisory group supports patient engagement, identifying key factors for success and challenges to address.

## Contribution

The paper provides a mixed-methods evaluation of a cancer care patient advisory group, offering insights into effective engagement strategies and challenges.

## Key findings

- Facilitators of engagement include coordination, mutual respect, belonging, and co-learning.
- PAG members felt very engaged, but 20% of survey responses were marked as 'not applicable.'
- Challenges included a desire for more impact understanding and education about the project.

## Abstract

Patient engagement is associated with improved care quality, better health outcomes, increased trust and satisfaction, and reduced costs. Patient engagement is recommended in cancer care. Patient advisory groups (PAGs) are a commonly used approach for engaging patients. However, more evidence is needed to understand how effectively PAGs support meaningful engagement, what factors shape that engagement, and how their contributions align with program goals. This study used a mixed‐methods approach to evaluate patient engagement within a PAG supporting an oncology quality improvement initiative.

The Oncology Equity Alliance (OEA), a quality improvement initiative to improve care coordination and reduce time to treatment, established a PAG to engage patients throughout the initiative. We conducted a mixed‐method evaluation of PAG engagement. Focus groups with PAG members and qualitative interviews with OEA team members were rapidly analyzed to identify engagement successes and challenges, and to determine engagement principles to focus on for survey evaluation. Perceptions of PAG engagement were assessed via surveys of PAG members and OEA team members, using selected items from the Research Engagement Survey Tool (REST). Surveys were analyzed descriptively and according to the REST scoring scheme.

Focus groups (n = 2) and interviews (n = 3) identified key facilitators that supported engagement including deliberate coordination, mutual respect, a sense of belonging, and co‐learning. Engagement was also positively impacted by members' motivations for joining the PAG and practical and logistical considerations. Challenges included PAG members' desire for greater understanding of the project's impact, more agenda setting, and ongoing education about OEA core components. This qualitative data informed the selection of engagement principles of focus for quantitative evaluation using REST. A total of 80% of PAG members (n = 10) felt very engaged, with the degree of engagement corresponding to cooperation and collaboration domains; however, for individual survey items, an average of 20% of responses were marked by PAG members as “not applicable.”

This mixed‐method evaluation found strong alignment between program goals and PAG member engagement, highlighted effective strategies, and identified addressable challenges. As patient engagement becomes more common in cancer care, applying these lessons is essential to advancing meaningful, person‐centered programs.

This paper presents an evaluation of a PAG. In addition to being the study participants, the members of the patient advisory group participated in member checking to validate the study findings, ensuring that the interpretations reflected their experiences and perspectives.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** PTGER4 (prostaglandin E receptor 4) [NCBI Gene 5734] {aka EP4, EP4R}, PTGER1 (prostaglandin E receptor 1) [NCBI Gene 5731] {aka EP1}, PTGER2 (prostaglandin E receptor 2) [NCBI Gene 5732] {aka COX-2, EP2}
- **Diseases:** Cancer (MESH:D009369)
- **Chemicals:** PAG (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], Pyrenochaetopsis sp. AG (species) [taxon 1852192]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12831170/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12831170/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12831170/full.md

---
Source: https://tomesphere.com/paper/PMC12831170